Genentech oncology head leaves for Bellicum CEO role
February 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bellicum, Genentech, Roche, tecentriq
Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …
MSD’s drug given European approval for first-line treatment in NSCLC
February 1, 2017Sales and Marketing European Commission, MSD, Merck
The good news keeps coming for MSD, known as Merck in North America, and Keytruda, with a further label expansion …
Sanofi & Regeneron’s arthritis drug scores first approval following FDA rejection
February 1, 2017Research and Development, Sales and Marketing Actemra, Humira, Kevzara, Regeneron, Roche, Sanofi, sarilumab
Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …
Potential treatment for opioid withdrawal discovered
February 1, 2017Medical Communications, Research and Development University of Calgary, gout, opioid
Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …
Italian firm warned by FDA over record-shredding and drug quality misrepresentation
February 1, 2017Manufacturing and Production, Research and Development FACTA Farmaceutici, FDA
Italian drug manufacturer FACTA Farmaceutici has been issued a warning letter by the FDA after being found shredding “critical laboratory …
African Heads of State commit to universal access to immunisation
February 1, 2017Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation
The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …
Trump meets with top pharma execs, reiterates pledge to lower “astronomical” prices
January 31, 2017Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Eli Lilly, Novartis, PhRMA, Trump
President Trump convened with a number of top pharma execs at the White House on Tuesday to discuss the key …
Antitrust investigation into Mylan begins over EpiPen
January 31, 2017Research and Development, Sales and Marketing Mylan, pricing
The Federal Trade Commission has submitted a request to Mylan for information as part of a preliminary investigation into whether …
First-line malaria treatment fails for the first time in UK
January 31, 2017Manufacturing and Production, Research and Development UK, malaria
The key combination malaria therapy artemether-lumefantrine has failed to treat UK patients for the first time, suggesting that the parasite …
Price-fixing class action lawsuit levelled at three major insulin producers
January 31, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing
A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …
Trump’s “one in, two out” regulatory order threatens FDA, Obama Cures Act
January 31, 2017Manufacturing and Production, Sales and Marketing FDA, Trump
An executive order signed by President Donald Trump on Monday has caused concern in the US pharma industry and beyond …
Teva hit by patent blow upon top-selling MS drug
January 31, 2017Manufacturing and Production Mylan, Teva, generic, multiple sclerosis
Teva endured a rough ride in 2016, seeing its market value sink progressively over the course of the year. It …
1,100% generic cancer drug price increases fly below UK radar
January 30, 2017Manufacturing and Production, Sales and Marketing Drug pricing, European Cancer congress
If you were asked what the big topic of discussion in the pharmaceutical industry was last year, there would really …
Sanofi announces new VP of External Affairs
January 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi
Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …
Major pharma firms join Liverpool Uni in £14m pharmacovigilance project
January 30, 2017Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance
The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …
Astellas and Ironwood release positive Phase 3 results for constipation drug
January 30, 2017Research and Development, Sales and Marketing Astellas, Ironwood, constipation
Astellas Pharma, a Tokyo-based pharmaceutical, and Ironwood Pharmaceuticals, based in Cambridge, Massachusetts, have announced positive results from a Phase 3 …
MSD puts best foot forward in drug pricing debate
January 30, 2017Medical Communications, Sales and Marketing Drug pricing, MSD, Merck
MSD, known as Merck in North America, has taken a pre-emptive step in the drug pricing debate by releasing its …
Amgen drug pair become first Humira biosimilars to win EU approval
January 30, 2017Sales and Marketing AbbVie, Amgen, Amgevita, Humira, Solymbic, rheumatoid arthritis
Good news for Amgen as its two biosimilar versions of AbbVie’s blockbuster rheumatoid arthritis (RA) drug Humira (adalimumab) have been …
Novo Nordisk launches £115 million investment in UK despite Brexit
January 30, 2017Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit
Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …
Juno Therapeutics bring in new executive vice president
January 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics
Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
